With the 15% bulk discount on 5+ vials, the effective cost drops to66,470 per vial 1,329 per mg a saving of approximately58,650 on a five-vial order (391,000 down to 332,350)
Lower bioavailability than injection
PLEASE VISIT THE RESOURCES TAB FOR GOVERNING DOCUMENTS, DESIGN GUIDELINES, AND ADDITIONAL INFORMATION.
KPV: Best for inflammatory pain and conditions Why KPV is superior for inflammation: Extremely potent anti-inflammatory peptide Reduces IL-6, TNF-alpha, other inflammatory markers Modulates immune response Works systemically Best for: Rheumatoid arthritis Autoimmune-related pain Inflammatory bowel disease with pain Chronic systemic inflammation Widespread pain from inflammation Dosing: Injectable: 500-1,000mcg daily subcutaneous Oral: 1-2mg daily for gut-specific inflammation 8-12 weeks minimum Can use long-term Expected results: Week 2-4: Reduced inflammatory markers Week 4-8: Decreased pain levels Week 8-12: Significant inflammation control Comparison to NSAIDs: KPV: Reduces inflammation without stomach damage NSAIDs: Temporary relief, stomach/kidney risks KPV safer long-term BPC-157 for inflammation + tissue healing Why BPC-157 for inflammatory pain: Anti-inflammatory effects Also heals tissue causing inflammation Dual benefit Best for: Inflammatory pain with tissue damage IBD/Crohn's (gut inflammation) General inflammatory conditions Can combine KPV + BPC-157: KPV: Powerful inflammation reduction BPC-157: Tissue healing Together = comprehensive inflammatory pain relief Best peptide for chronic widespread pain Fibromyalgia, chronic pain syndrome, multi-site pain
16%, respectively)
Materials and Methods Cell culture Two commercial GBM cell lines, U-87MG (HTB-14, American Type Culture Collection ATCC, Manassas, Virginia, USA) and U251 (09063001, European Collection of Authenticated Cell Cultures ECACC, Salisbury, United Kingdom) were used
